Injectco review
A monthly subscription for each molecule, beside long packages quoted only at the starting dose.
The verdict
Injectco prices a compounded semaglutide subscription from $249 a month and tirzepatide from $425. It also sells six-to-eight month packages, and those are quoted at the starting dose only.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $249/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Injectco is a Texas medical aesthetics clinic that sells compounded semaglutide and tirzepatide alongside its other treatments. Each molecule has a monthly price and a longer package.
Who writes the prescription, and what do they see?
A virtual consultation with an Injectco clinician sets the medication and the dosing, and the package price is stated to include that consultation. The clinic is a physical practice rather than a mail-order brand, which is worth knowing before a first call.
The semaglutide subscription delivers medication monthly with a home kit. A single payment instead buys a long run of medication and the consultation that starts it. Payment plans are offered. The clinic states no membership costs and no hidden fees.
What happens when the dose goes up?
The package supply is stated at the starting dose, and that qualifier does the real work. A titration draws the same vial down faster, so the eight-month end of the range belongs to a buyer who does not escalate. Nothing published says what a step up costs on either route.
What the price includes
Six months of the subscription is $1,494 for semaglutide and $2,550 for tirzepatide. Package prices of $1,249 and $1,620 for a six-to-eight month supply both appear on the site, the lower on a page that names no molecule. A buyer who escalates on schedule will exhaust a package nearer the short end of its range.
What it claims, and what it cites
The GLP-1 line is a compounded preparation rather than a manufactured product, and the compounding pharmacy is not named. The FDA does not review a compounded preparation before it is dispensed.
Where it holds up, and where it does not
- Strength: A monthly subscription with a home kit
- Strength: Provider consult included in the package
- Strength: Payment plans offered
- Strength: No membership fee stated
- Limitation: Package supply quoted at the starting dose only
- Limitation: A dose increase shortens a package
- Limitation: Two package prices appear on the site
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Injectco. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who wants to pay monthly and keep a long package as an option.
- Wrong for
- A buyer escalating on schedule who is counting on a package to last eight months.
The evidence behind what Injectco prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Injectco compares
| Seller | Who it suits | Go |
|---|---|---|
 RxPepsDirect | Buyers at a starting dose who want per-vial pricing and no subscription | See RxPepsDirect → |
 HeliMeds | Buyers converting a twelve-week plan into calendar months before comparing it | See HeliMeds → |
| Alegro Health | Buyers trying a GLP-1 for two months before committing to a rate | See Alegro Health → |
More GLP-1 telehealth sellers reviews: EOS HealthEveEverlywell (Weight Care+)EverSlimEviora MDFactor Health MD
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is there a cheaper way to buy semaglutide?
- A $1,249 package covers six to eight months at the starting dose. The subscription starts at $249 a month.
- Does a dose increase change the supply?
- The supply is quoted at the starting dose, so escalating draws it down faster. Nothing published states the cost of topping it up.
- What does tirzepatide cost?
- $425 a month on its own program.
- Is Injectco expensive compared with other GLP-1 telehealth sellers?
- Injectco publishes a starting figure of $249/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Injectco above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.